IL13RA1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.745800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.734600E-01
Normal-vs-Stage2
7.222000E-01
Normal-vs-Stage3
5.395200E-01
Normal-vs-Stage4
3.962400E-01
Stage1-vs-Stage2
5.191900E-02
Stage1-vs-Stage3
5.160000E-01
Stage1-vs-Stage4
4.929900E-02
Stage2-vs-Stage3
2.099200E-01
Stage2-vs-Stage4
5.564800E-01
Stage3-vs-Stage4
1.177220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.253600E-01
Normal-vs-AfricanAmerican
6.359800E-01
Normal-vs-Asian
8.459400E-01
Caucasian-vs-AfricanAmerican
6.025800E-01
Caucasian-vs-Asian
9.612200E-01
AfricanAmerican-vs-Asian
7.246600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.120000E-01
Normal-vs-Female
7.350200E-01
Male-vs-Female
7.902600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.219000E-01
Normal-vs-Age(41-60Yrs)
3.098800E-01
Normal-vs-Age(61-80Yrs)
9.739000E-01
Normal-vs-Age(81-100Yrs)
4.134800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.497200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.918800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.685400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.010870E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.93440000000012E-05
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.460000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.425200E-01
Normal-vs-Daily Drinker
9.208400E-01
Normal-vs-Weekly Drinker
7.667400E-01
Normal-vs-Occasional Drinker
4.971000E-01
Normal-vs-Social Drinker
5.801200E-01
Non Drinker-vs-Daily Drinker
9.231200E-01
Non Drinker-vs-Weekly Drinker
4.947200E-01
Non Drinker-vs-Occasional Drinker
1.652590E-01
Non Drinker-vs-Social Drinker
2.436200E-01
Daily Drinker-vs-Weekly Drinker
5.187000E-01
Daily Drinker-vs-Occasional Drinker
2.139000E-01
Daily Drinker-vs-Social Drinker
2.938400E-01
Weekly Drinker-vs-Occasional Drinker
5.686600E-01
Weekly Drinker-vs-Social Drinker
6.695000E-01
Occasional Drinker-vs-Social Drinker
9.206600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.830600E-01
Normal-vs-Grade 2
6.858800E-01
Normal-vs-Grade 3
6.743400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.365400E-01
Grade 1-vs-Grade 3
6.480200E-01
Grade 1-vs-Grade 4
4.830600E-01
Grade 2-vs-Grade 3
7.966400E-01
Grade 2-vs-Grade 4
6.858800E-01
Grade 3-vs-Grade 4
6.743400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.942200E-01
Normal-vs-NonDiabetic
7.172800E-01
Diabetic-vs-NonDiabetic
5.506200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.448000E-01
Normal-vs-NoPancreatitis
8.440200E-01
Pancreatitis-vs-NoPancreatitis
9.979400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.428800E-01
Normal-vs-N1
7.054200E-01
N0-vs-N1
2.483800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.116200E-01
Normal-vs-TP53-NonMutant
8.345000E-01
TP53-Mutant-vs-TP53-NonMutant
2.291600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
